Abstract
Neurodegenerative diseases are characterized by the neurodegenerative changes or apoptosis of neurons involved in networks, which are important to specific physiological functions. With the development of old-aging society, the incidence of neurodegenerative diseases is on the increase. However, it is difficult to diagnose for most of neurodegenerative diseases. At present, there are too few effective therapies. Advances in stem cell biology have raised the hope and possibility for the therapy of neurodegenerative diseases. Recently, stem cells have been widely attempted to treat neurodegenerative diseases of animal model. Here we review the progress and prospects of various stem cells, including embryonic stem cells, mesenchymal stem cell and neural stem cells and so on, for the treatments of neurodegenerative diseases, such as Parkinson’s disease, Alzheimer’s disease, Huntington’ disease and Amyotrophic lateral sclerosis/Lou Gehrig’s disease.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Lindvall O, Kokaia Z, Martinez-Serrano A. Stem cell therapy for human neurodegenerative disorders-How to make it work. Nat Med, 2004, 10: S42–S50,15272269, 10.1038/nm1064, 1:CAS:528:DC%2BD2cXlvVKgsrg%3D
Piccini P, Brooks D J, Bjorklund A, et al. Dopamine release from nigral transplants visualized in vivo in a Parkinson’s patient. Nat Neurosci, 1999, 2(12): 1137–1140, 10570493, 10.1038/16060, 1:CAS:528:DyaK1MXnslKqtLk%3D
Piccini P, Lindvall O, Bjorklund A, et al. Delayed recovery of movement-related cortical function in Parkinson’s disease after striatal dopaminergic grafts. Ann Neurol, 2000, 48(5): 689–695, 11079531, 10.1002/1531-8249(200011)48:5<689::AID-ANA1>3.0.CO;2-N, 1:STN:280:DC%2BD3M%2FkvVSjtg%3D%3D
Studer L, Tabar V, McKay R D. Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats. Nat Neurosci, 1998, 1(4): 290–295, 10195162, 10.1038/1105, 1:CAS:528:DyaK1MXitVCguro%3D
Lindvall O, Hagell P. Clinical observations after neural transplantation in Parkinson’s disease. Prog Brain Res, 2000, 127: 299–320, 11142032, 1:STN:280:DC%2BD3M7gsFKrtQ%3D%3D
Sanchez-Pernaute R, Studer L, Bankiewicz K S, et al. In vitro generation and transplantation of precursor-derived human dopamine neurons. J Neurosci Res, 2001, 65: 284–288, 11494363, 10.1002/jnr.1152, 1:CAS:528:DC%2BD3MXlvVGmsL0%3D
Polgar S, Morris M E, Reilly S, et al. Reconstructive neurosurgery for Parkinson’s disease: A systematic review and preliminary meta-analysis. Brain Res Bull, 2003, 60(1–2): 1–24, 12725889, 10.1016/S0361-9230(03)00017-0, 1:STN:280:DC%2BD3s3gsF2qtg%3D%3D
Freed C R, Greene P E, Breeze R E, et al. Transplantation of embryonic dopamine neurons for severe Parkinson’s disease. N Engl J Med, 2001, 344(10): 710–719,11236774, 10.1056/NEJM200103083441002, 1:STN:280:DC%2BD3M7ltFCisQ%3D%3D
Olanow C W, Goetz C G, Kordower J H, et al. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson’s disease. Ann Neurol, 2003, 54(3): 403–414,12953276, 10.1002/ana.10720
Bjorklund L M, Sanchez-Pernaute R, Chung S, et al. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci USA, 2002, 99(4): 2344–2349,11782534, 10.1073/pnas.022438099, 1:CAS:528:DC%2BD38XitVSrurg%3D
Kim J H, Auerbach J M, Rodriguez-Gomez J A, et al. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson’s disease. Nature, 2002, 418(6893): 50–56, 12077607, 10.1038/nature00900, 1:CAS:528:DC%2BD38XltVantrc%3D
Nishimura F, Yoshikawa M, Kanda S, et al. Potential use of embryonic stem cells for the treatment of mouse parkinsonian models: Improved behavior by transplantation of in vitro differentiated dopaminergic neurons from embryonic stem cells. Stem Cells, 2003, 21(2): 171–180, 12634413, 10.1634/stemcells.21-2-171
Takagi Y, Takahashi J, Saiki H, et al. Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model. J Clin Invest, 2005, 115(1): 102–109,15630449, 1:CAS:528:DC%2BD2MXis1ersw%3D%3D
Hellmann M A, Panet H, Barhum Y, et al. Increased survival and migration of engrafted mesenchymal bone marrow stem cells in 6-hydroxydopamine-lesioned rodents. Neurosci Lett, 2006, 395(2): 124–128,16359791, 10.1016/j.neulet.2005.10.097, 1:CAS:528:DC%2BD28XhtValtrs%3D
Weiss M L, Medicetty S, Bledsoe A R, et al. Human umbilical cord matrix stem cells: Preliminary characterization and effect of transplantation in a rodent model of Parkinson’s disease. Stem Cells, 2006, 24(3): 781–792, 16223852, 10.1634/stemcells.2005-0330, 1:CAS:528:DC%2BD28XhtFKiur%2FN
Fu Y S, Cheng Y C, Lin M Y, et al. Conversion of human umbilical cord mesenchymal stem cells in wharton’s jelly to dopaminergic neurons in vitro: Potential therapeutic application for Parkinsonism. Stem Cells, 2006, 24(1): 115–124, 16099997, 10.1634/stemcells.2005-0053
Crigler L, Robey R C, Asawachaicharn A, et al. Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis. Exp Neurol, 2006, 198: 54–64,16336965, 10.1016/j.expneurol.2005.10.029, 1:CAS:528:DC%2BD28Xhs1Snsrk%3D
Munoz J R, Stoutenger B R, Robinson A P, et al. Human stem/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice. Proc Natl Acad Sci USA, 2005, 102(50): 18171–18176,16330757, 10.1073/pnas.0508945102, 1:CAS:528:DC%2BD2MXhtlersrvN
Harrower T P, Tyers P, Hooks Y, et al. Long-term survival and integration of porcine expanded neural precursor cell grafts in a rat model of Parkinson’s disease. Exp Neurol, 2006, 197(1): 56–69,16246328, 1:STN:280:DC%2BD2MnovVentw%3D%3D
Bjugstad K B, Redmond D E, Teng Y D, et al. Neural stem cells implanted into MPTP-treated monkeys increase the size of endogenous tyrosine hydroxylase-positive cells found in the striatum: A return to control measures. Cell Transplant, 2005, 14(4): 183–192,15929553
Redmond D E, Bjugstad K B, Teng Y D, et al. Behavioral improvement in a primate Parkinson’s model is associated with multiple homeostatic effects of human neural stem cells. Proc Natl Acad Sci USA, 2007, 104(29): 12175–12180,17586681, 10.1073/pnas.0704091104, 1:CAS:528:DC%2BD2sXosVersb0%3D
Auld D S, Kornecook T J, Bastianetto S, et al. Alzheimer’s disease and the basal forebrain cholinergic system: Relations to β-amyloid peptides, cognition, and treatment strategies. Prog Neurobiol, 2002, 68: 209–245,12450488, 10.1016/S0301-0082(02)00079-5, 1:CAS:528:DC%2BD38XovFeiurk%3D
German D C, Yazdani U, Speciale S G, et al. Cholinergic neuropathology in a mouse model of Alzheimer’s disease. J Comp Neurol, 2003, 462: 371–373, 12811807, 10.1002/cne.10737
Martinez-Serrano A, Hantzopoulos P A, Bjorklund A. Ex vivo gene transfer of brain-derived neurotrophic factor to the intact rat forebrain: Neurotrophic effects on cholinergic neurons. Eur J Neurosci, 1996, 8: 727–735, 9081624, 10.1111/j.1460-9568.1996.tb01258.x, 1:STN:280:DyaK2s7htVyntQ%3D%3D
Sinden J D, Stroemer P, Grigoryan G, et al. Functional repair with neural stem cells. Novartis Found Symp, 2000, 231: 270–283, 11131543, 1:STN:280:DC%2BD3M7jsleisA%3D%3D
Qu T, Brannen C L, Kim H M, et al. Human neural stem cells improve cognitive function of aged brain. Neuroreport, 2001, 12: 1127–1132,11338178, 10.1097/00001756-200105080-00016, 1:STN:280:DC%2BD3MrgsFSntQ%3D%3D
Wu P, Tarasenko Y I, Gu Y, et al. Region-specific generation of cholinergic neurons from fetal human neural stem cells grafted in adult rat. Nat Neurosci, 2002, 5: 1271–1278,12426573, 10.1038/nn974, 1:CAS:528:DC%2BD38XovFChs7g%3D
Wang Q, Matsumoto Y, Shindo T, et al. Neural stem cells transplantation in cortex in a mouse model of Alzheimer’s disease. J Med Invest. 2006, 53(1–2): 61–69,16537997, 10.2152/jmi.53.61
Sugaya K, Kim H M, Qu T, et al. Physiological role of amyloid beta precursor protein in neural stem cell biology. Program No. 132.15. Abstract Viewer/Itinerary Planner. Washington: Society for Neuroscience, 2001
Kirazov E, Kirazov L, Bigl V, et al. Ontogenetic changes in protein level of amyloid precursor protein (APP) in growth cones and synaptosomes from rat brain and prenatal expression pattern of APP mRNA isoforms in developing rat embryo. Int J Dev Neurosci, 2001, 19: 287–296,11337197, 10.1016/S0736-5748(01)00012-0, 1:CAS:528:DC%2BD3MXjtFCltrk%3D
Murakami N, Yamaki T, Iwamoto Y, et al. Experimental brain injury induces expression of amyloid precursor protein, which may be related to neuronal loss in the hippocampus. J Neurotrauma, 1998, 15: 993–1003,9840772, 1:STN:280:DyaK1M%2FlsVGjtQ%3D%3D, 10.1089/neu.1998.15.993
Miyachi T, Asai K, Tsuiki H, et al. Interleukin-1beta induces the expression of lipocortin 1 mRNA in cultured rat cortical astrocytes. Neurosci Res, 2001, 40: 53–60, 11311405, 10.1016/S0168-0102(01)00208-5, 1:CAS:528:DC%2BD3MXislGqsr0%3D
Sugaya K, Alvarez A, Marutle A, et al. Stem cell strategies for Alzheimer’s disease therapy. Panminerva Med, 2006, 48(2): 87–96,16953146, 1:STN:280:DC%2BD28rivVymtA%3D%3D
Ende N, Chen R, Ende-Harris D. Human umbilical cord blood cells ameliorate Alzheimer’s disease in transgenic mice. J Med, 2001, 32(3–4): 241–247,11563821, 1:STN:280:DC%2BD3Mrhs1Gjtg%3D%3D
Chen C W, Boiteau R M, Lai W F, et al. sAPPalpha enhances the transdifferentiation of adult bone marrow progenitor cells to neuronal phenotypes. Curr Alzheimer Res, 2006, 3(1): 63–70,16472205, 10.2174/156720506775697205, 1:CAS:528:DC%2BD28XisVant70%3D
Pakzaban P, Deacon T, Burns L, et al. Increased proportion of AChE-rich zones and improved morphologic integration in host striatum of fetal grafts derived from the lateral but not the medial ganglionic eminence. Exp Brain Res, 1993, 97: 13–22,7907548, 10.1007/BF00228813, 1:STN:280:DyaK2c7nvVensw%3D%3D
Isacson O, Deacon T W, Pakzaban P, et al. Transplanted xenogeneic neural cells in neurodegenerative disease models exhibit remarkable axonal target specificity and distinct growth patterns of glial and axonal fibres. Nat Med, 1995, 1: 1189–1194, 7584993, 10.1038/nm1195-1189, 1:CAS:528:DyaK2MXptFahsL8%3D
Freeman T B, Sanberg P R, Isacson O. Development of the human striatum: Implications for fetal striatal transplantation. Cell Transplant, 1995, 4: 539–545, 8714776, 10.1016/0963-6897(95)00013-N, 1:STN:280:DyaK28zltVyjtQ%3D%3D
Hantraye P, Riche D, Maziere M, et al. Intrastriatal transplantation of cross-species fetal striatal cells reduces abnormal movements in a primate model of Huntington disease. Proc Natl Acad Sci USA, 1992, 89: 4187–4191,1533285, 10.1073/pnas.89.9.4187, 1:STN:280:DyaK383jslegsA%3D%3D
Kendall A L, Rayment F D, Torres E M, et al. Functional integration of striatal allografts in a primate model of Huntington’s disease. Nat Med, 1998, 4: 727–729, 9623985, 10.1038/nm0698-727, 1:CAS:528:DyaK1cXjsFyksbs%3D
Keene C D, Sonnen J A, Swanson P D, et al. Neural transplantation in Huntington disease: Long-term grafts in two patients. Neurology, 2007, 68(24): 2093–2098,17562830, 10.1212/01.wnl.0000264504.14301.f5, 1:STN:280:DC%2BD2szkvFWntg%3D%3D
Lescaudron L, Unni D, Dunbar G L. Autologous adult bone marrow stem cell transplantation in an animal model of huntington’s disease: Behavioral and morphological outcomes. Int J Neurosci, 2003, 113(7): 945–956,12881187, 10.1080/00207450390207759
McBride J L, Behrstock S P, Chen E Y, et al. Human neural stem cell transplants improve motor function in a rat model of Huntington’s disease. J Comp Neurol, 2004, 475(2): 211–219,15211462, 10.1002/cne.20176
Lee S T, Park J E, Lee K, et al. Noninvasive method of immortalized neural stem-like cell transplantation in an experimental model of Huntington’s disease. J Neurosci Methods, 2006, 152(1–2): 250–254,16257450, 10.1016/j.jneumeth.2005.09.013, 1:CAS:528:DC%2BD28Xit1aqsrY%3D
Lee S T, Chu K, Park J E, et al. Intravenous administration of human neural stem cells induces functional recovery in Huntington’s disease rat model. Neurosci Res, 2005, 52(3): 243–249,15896865, 10.1016/j.neures.2005.03.016, 1:CAS:528:DC%2BD2MXltVeiurk%3D
Roberts T J, Price J, Williams S C, et al. Preservation of striatal tissue and behavioral function after neural stem cell transplantation in a rat model of Huntington’s disease. Neuroscience, 2006, 139(4): 1187–1199, 16517087, 10.1016/j.neuroscience.2006.01.025, 1:CAS:528:DC%2BD28XktVGhurw%3D
Vazey E M, Chen K, Hughes S M, et al. Transplanted adult neural progenitor cells survive, differentiate and reduce motor function impairment in a rodent model of Huntington’s disease. Exp Neurol, 2006,199: 384–396,16626705, 10.1016/j.expneurol.2006.01.034
Johann V, Schiefer J, Sass C, et al. Time of transplantation and cell preparation determine neural stem cell survival in a mouse model of Huntington’s disease. Exp Brain Res, 2007, 177(4): 458–470,17013619, 10.1007/s00221-006-0689-y
Bachoud-Levi A C, Gaura V, Brugieres P, et al. Effect of fetal neural transplants in patients with Huntington’s disease 6 years after surgery: A long term follow up study. Lancet Neurol, 2006, 5: 303–309,16545746, 10.1016/S1474-4422(06)70381-7
Roberts T J, Price J, Williams S C, et al. Preservation of striatal tissue and behavioral function after neural stem cell transplantation in a rat model of Huntington’s disease. Neuroscience, 2006, 139(4): 1187–1199,16517087, 10.1016/j.neuroscience.2006.01.025, 1:CAS:528:DC%2BD28XktVGhurw%3D
Isacson O. The production and use of cells as therapeutic agents in neurodegenerative diseases. Lancet Neurol, 2003, 2: 417–424,12849120, 10.1016/S1474-4422(03)00437-X, 1:CAS:528:DC%2BD3sXms1yhsLc%3D
Wichterle H, Lieberam I, Porter J, et al. Directed differentiation of embryonic stem cells into motor neurons. Cell, 2002, 110: 385–397,12176325, 10.1016/S0092-8674(02)00835-8, 1:CAS:528:DC%2BD38Xmtl2rs70%3D
Iwanami A, Kaneko S, Nakamura M, et al. Transplantation of human neural stem cells for spinal cord injury in primates. J Neurosci Res, 2005, 80(2): 182–190, 15772979, 10.1002/jnr.20436, 1:CAS:528:DC%2BD2MXjtFajtr4%3D
Mazzini L, Mareschi K, Ferrero I, et al. Autologous mesenchymal stem cells: Clinical applications in amyotrophic lateral sclerosis. Neurol Res, 2006, 28(5): 523–526, 16808883, 10.1179/016164106X116791
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by the Talented Person Foundation of Beijing Jiaotong University (Grand No. 2004RC048) and the Great Science and Technology Foundation of Beijing Jiaotong University (Grand No. 2004SZ010)
Rights and permissions
About this article
Cite this article
Hou, L., Hong, T. Stem cells and neurodegenerative diseases. SCI CHINA SER C 51, 287–294 (2008). https://doi.org/10.1007/s11427-008-0049-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11427-008-0049-1